SAO PAULO:A coronavirus vaccine developed by China's Sinovac Biotech was just 50.4% effective at preventing symptomatic infections in a Brazilian trial, researchers said on Tuesday, barely enough for regulatory approval and well below the rate announced last week.
The latest results are a major disappointment for Brazil, as the Chinese vaccine is one of two that the federal government has lined up to begin immunization during the second wave of the world's second-deadliest COVID-19 outbreak.
Several scientists and observers blasted the Butantan biomedical center for releasing partial data just days ago that generated unrealistic expectations. The confusion may add to skepticism in Brazil about the Chinese vaccine, which President Jair Bolsonaro has criticized, questioning its "origins."
"We have a good vaccine. Not the best vaccine in the world. Not the ideal vaccine," said microbiologist Natalia Pasternak, criticizing Butantan's triumphant tone.
Last week, the Brazilian researchers had celebrated results showing 78% efficacy against "mild-to-severe" COVID-19 cases, a rate they later described as "clinical efficacy."
They said nothing at the time about another group of "very mild" infections among those who received the vaccine that did not require clinical assistance.
Ricardo Palacios, medical director for clinical research at Butantan, said on Tuesday that the new lower efficacy finding included data on those "very mild" cases.
"We need better communicators," said Gonzalo Vecina Neto, a professor of public health at the University of Sao Paulo and former head of Brazilian health regulator Anvisa.
Piecemeal disclosures about Chinese vaccine trials globally have raised concerns that they are not subject to the same public scrutiny as U.S. and European alternatives.
Palacios and officials in the Sao Paulo state government, which funds Butantan, emphasized the good news that none of the volunteers inoculated with CoronaVac had to be hospitalized with COVID-19 symptoms.
Public health experts said that alone will be a relief for Brazilian hospitals that are buckling under the strain of surging case loads. However, it will take longer to curb the pandemic with a vaccine that allows so many mild cases.
"It's a vaccine that will start the process of overcoming the pandemic," Pasternak said.
DELAYS AND DISAPPOINTMENT
Researchers at Butantan delayed announcement of their results three times, blaming a confidentiality clause in a contract with Sinovac.
In the meantime, Turkish researchers said last month that CoronaVac was 91.25% effective based on an interim analysis. Indonesia gave the vaccine emergency use approval on Monday based on interim data showing it is 65% effective.
Butantan officials said the design of the Brazilian study, focusing on frontline health workers during a severe outbreak in Brazil and including elderly volunteers, made it impossible to compare the results directly with other trials or vaccines.
Still, COVID-19 vaccines in use from Pfizer Inc with partner BioNTech SE and Moderna Inc proved to be about 95% effective in preventing illness in their pivotal late-state trials.
The disappointing CoronaVac data is the latest setback for vaccination efforts in Brazil, where more than 200,000 people have died since the outbreak began - the worst death toll outside the United States.
Brazil's national immunization program currently relies on CoronaVac and the vaccine developed by Oxford University and AstraZeneca Plc - neither of which has received regulatory approval in Brazil.
Anvisa, which has stipulated an efficacy rate of at least 50% for vaccines in the pandemic, has already pressed Butantan for more details of its study, after it filed for emergency use authorization on Friday.
The regulator said it will meet on Sunday to decide on emergency use requests for CoronaVac and the British vaccine.
AstraZeneca failed to deliver active ingredients to Brazil over the weekend, leaving the government scrambling to import finished doses of the vaccine from India to begin inoculations.
Reuters
Wed Jan 13 2021
Piecemeal disclosures about Chinese vaccine trials globally have raised concerns that they are not subject to the same public scrutiny as U.S. and European alternatives. - China Daily via REUTERS
Korea Selatan pindahkan 97 rakyatnya dari Lubnan
Kementerian Luar Korea Selatan maklumkan, kesemua mereka tiba di Korea Selatan pada petang Sabtu.
Pelarian tiba di Syria selepas serangan Israel ke atas Lubnan - UNHCR
Lebih 200,000 warga Syria dan Lubnan telah tiba di Syria dari Lubnan sejak serangan Israel bermula 23 September lalu.
[LAPOR LANGSUNG] Lebih 2,000 terkorban di Lubnan akibat serangan Israel
Jumlah mangsa yang maut itu termasuk 261 wanita dan 127 kanak-kanak.
Lebih 2,000 terkorban di Lubnan akibat serangan Israel
Laporan Al Jazeera menyebut, jumlah mangsa yang maut itu termasuk 261 wanita dan 127 kanak-kanak.
AWANI Pagi: Pendayaupayaan Pembangunan Sosio Ekonomi Bagi Memacu Wilayah Persekutuan
Ikuti temu bual bersama Menteri di Jabatan Perdana Menteri (Wilayah Persekutuan), Dr Zaliha Mustafa di #AWANIPagi jam 7.30 pagi di saluran 501 Astro AWANI.
Pentagon, Jabatan Negara AS beri amaran jenayah perang Israel
Pegawai-pegawai tersebut telah memberi amaran peningkatan jumlah kematian di Gaza mungkin melanggar undang-undang antarabangsa.
200,000 pelarian tiba di Syria selepas serangan Israel ke atas Lubnan - UNHCR
Lebih 200,000 warga Syria dan Lubnan telah tiba di Syria dari Lubnan sejak serangan Israel bermula pada 23 Sept.
Belanjawan 2025: Kesalinghubungan internet di sekolah, kampus jadi keutamaan - Fahmi
Kementerian Komunikasi akan memberikan keutamaan dengan meneruskan usaha untuk meningkatkan dan memantapkan lagi prasarana kesalinghubungan melibatkan isu Internet, dalam Belanjawan 2025 yang akan dibentangkan pada 18 Okt ini.
Setahun solidariti, sokongan global untuk Palestin di tengah-tengah genosid berterusan Israel
Ribuan manusia di seluruh dunia turun ke jalanan untuk menyuarakan sokongan kepada Palestin dan menuntut keadilan.
Indonesia kecewakan China, raih kejuaraan badminton berpasukan campuran remaja dunia
Indonesia menewaskan China untuk muncul Juara Badminton Berpasukan Campuran Remaja Dunia dengan kemenangan 110-103 (mata terkumpul).
Rai ulang tahun ke-125, alumni Convent Bukit Nanas anjur majlis makan malam 2 November
Sejak pandemik COVID-19 bermula, Persatuan Alumni Convent Bukit Nanas (CBN) memulakan inisiatif memberi sokongan kepada pelajar terkesan dengan melancarkan program bantuan untuk pelajar B40.
Felda mahu pupuk hubungan perniagaan Malaysia dan Indonesia
Felda bersedia untuk menghubungkan syarikat Malaysia, khususnya unit perniagaannya dengan firma dalam KEIND untuk meneroka peluang baharu di kedua-dua negara dan antarabangsa.
COVID-19 jejas kemajuan dalam mengurangi kemiskinan - KRI
Kemiskinan mutlak meningkat dari 2019 hingga 2022, terutamanya dalam kalangan isi rumah bandar, menokok kepada 4.5 peratus menjelang 2022 berbanding hanya 3.8 peratus pada 2019.
Invest Malaysia Iskandar 2024: Gerbang pertumbuhan ekonomi Asia Tenggara
Menjelang Invest Malaysia Iskandar 2024 esok, jangkaan semakin meningkat untuk acara penting ini yang telah meletakkan kedudukannya sebagai platform utama dalam membentuk masa depan pelaburan.
Perintah Mahkamah Majistret halang Siti Kasim daripada perhimpunan 2022 adalah sah
Hakim memutuskan perintah itu dikeluarkan untuk mengawal atau mencegah penyebaran virus COVID-19 pada masa itu.
Amazon arahkan pekerja kembali bekerja di pejabat lima hari seminggu
Pekerja Amazon diarah kembali bekerja sepenuh masa di pejabat, dengan menekankan kepentingan bekerja secara bersemuka.
Makanan tradisional Bajau Seri Semporna ubati kerinduan perantau
Meskipun nasib tidak menyebelahi Azreena apabila terpaksa menutup restoran ketika musim pandemik, setahun kemudian mereka mampu bangkit kembali.
Pesta Air Kuala Perlis medium rapatkan hubungan masyarakat
Pesta Air Kuala Perlis antara acara tradisi di Perlis sejak tahun 50-an, kini kembali selepas kali terakhir dianjurkan pada 2019.
MyPELINDUNG 2024: Jamin kehidupan selamat bersama COVID-19
Kempen MyPELINDUNG 2024 terus membantu rakyat Malaysia untuk menyesuaikan diri dengan norma baharu.
Konsulat Malaysia di Pontianak anjur majlis resepsi Hari Kebangsaan ke-67
Konsulat Malaysia di Pontianak, Kalimantan Barat mengadakan majlis resepsi Hari Kebangsaan ke-67 pada malam Sabtu yang dihadiri 300 tetamu termasuk Pemangku Gabenor Kalimantan Barat, Harisson dan iste